Managing metastatic renal cell carcinoma-challenges, pitfalls, and outcomes in the real world

INTRODUCTION: Renal cell carcinoma (RCC) is the most common cancer of the kidney accounting for 85% of renal tumors. Metastatic RCC (mRCC) had a poor prognosis and with the introduction of tyrosine-kinase inhibitors, such as sunitinib, pazopanib the outcomes improved. There is only one study reporte...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Karnam Ashok, Sadashivudu, Gundeti, Krishnamani, K. V., Linga, Vijay Gandhi, Maddali, Lakshmi Srinivas, Digumarti, Raghunadha Rao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234163/
https://www.ncbi.nlm.nih.gov/pubmed/28144093
http://dx.doi.org/10.4103/0971-5851.195738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234163/
https://www.ncbi.nlm.nih.gov/pubmed/28144093
http://dx.doi.org/10.4103/0971-5851.195738

Ejemplares similares